MCMCB Pro
J2370

J2370Injection, phenylephrine hcl, up to 1 ml

HCPCSTerminatedBETOS O1E

J2370 is a HCPCS Level II code for injection, phenylephrine hcl, up to 1 ml. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on June 30, 2023 and is not valid on new claims.

This code has been terminated

CMS terminated J2370 on June 30, 2023. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J2370

Long descriptor
Injection, phenylephrine hcl, up to 1 ml

The official wording. This is what the code means.

Short descriptor
Phenylephrine hcl injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1982

When CMS introduced the code.

Terminated
June 30, 2023

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J2370

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2370 is not quite right, the correct code is very often within a few positions of it.

  • J2354Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
  • J2355Injection, oprelvekin, 5 mg
  • J2356Injection, tezepelumab-ekko, 1 mg
  • J2357Injection, omalizumab, 5 mg
  • J2358Injection, olanzapine, long-acting, 1 mg
  • J2359Injection, olanzapine, 0.5 mg
  • J2360Injection, orphenadrine citrate, up to 60 mg
  • J2361Injection, depemokimab-ulaa, 1 mg
  • J2371Injection, phenylephrine hydrochloride, 20 micrograms
  • J2372Injection, phenylephrine hydrochloride (biorphen), 20 micrograms
  • J2373Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms
  • J2374Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml
  • J2400Injection, chloroprocaine hydrochloride, per 30 mlterminated
  • J2401Injection, chloroprocaine hydrochloride, per 1 mg
  • J2402Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
  • J2403Chloroprocaine hcl ophthalmic, 3% gel, 1 mg

Questions about J2370

What is HCPCS code J2370?

J2370 is a HCPCS Level II code for injection, phenylephrine hcl, up to 1 ml. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J2370?

The CMS HCPCS file marks J2370 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

Is J2370 still valid?

No. J2370 was terminated on June 30, 2023 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026